Streetbeat News

Partnerships

AMT

BLZE

Backblaze, Inc. (NASDAQ:BLZE) is leveraging CoreSite's colocation and connectivity solutions to expand its cloud storage services in the eastern U.S. data region. CoreSite, a subsidiary of American Tower Corporation (NYSE:AMT), provides Backblaze with geographic diversity and an exabyte of capacity to support growing customer needs. The partnership also allows Backblaze customers to replicate their data from hyperscale cloud providers, including AWS and its Amazon S3 platform, to the Backblaze platform without egress fees.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:13 pm

NVDA

RXRX

Recursion (NASDAQ:RXRX) has announced a data collaboration deal with Tempus Labs, an ambition to build a top 50 supercomputer powered by NVIDIA (NASDAQ:NVDA), and an updated focus of collaboration with Bayer in precision oncology. Recursion will pay Tempus up to $160M over the next five years for access to one of the world's largest proprietary oncology datasets. The company also plans to quadruple its supercomputing power with NVIDIA's support. Additionally, Recursion and Bayer will initiate up to seven oncology programs, with Recursion eligible to receive up to $1.5 billion plus royalties on net sales.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:12 pm

ATRA

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shares dropped after the company announced that its Phase 2 EMBOLD study of ATA188 in non-active progressive multiple sclerosis (PMS) did not meet the primary endpoint. The company is reviewing the data and plans to reduce expenses on ATA188, focusing more on its allogeneic CAR-T pipeline and the expanded tab-cel partnership with Pierre Fabre. This strategy is expected to extend the cash runway beyond Q3 of 2025.

Portfolio Pulse from Nabaparna Bhattacharya

November 09, 2023 | 1:09 pm

MYNZ

Mainz Biomed has partnered with Liquid Biosciences to extend the use of EMERGE in its product development pipeline. This includes analysis of its eAArly DETECT study and the forthcoming U.S. pivotal FDA PMA trial (ReconAAsense). If successful, this will allow Mainz Biomed to advance its current test's capabilities and commercialize a next-generation colorectal cancer screening tool. The eAArly DETECT clinical trial is enrolling 265 subjects across 22 sites and is expected to report results in Q4 2023.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 1:07 pm

CLMB

Climb Channel Solutions, a subsidiary of Climb Global Solutions, has entered into a partnership agreement to distribute GitLab to authorized resellers.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:54 pm

GOOGL

XMTR

Xometry has announced a contract with Google Cloud to leverage Vertex AI to accelerate the deployment of new auto-quote methods and models.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:38 pm

LILM

Lilium has entered into a partnership with Michelin for the development and serial production of tires for the Lilium Jet. The partnership aims to create custom, sustainable, and high-performance tires for the electric vertical take-off and landing (eVTOL) aircraft.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:33 pm

CENX

Century Aluminum Company has ratified a new five-year collective bargaining agreement with the United Steelworkers Local 9443-00 for the Century Sebree Aluminum Smelter in Robards.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:27 pm

FCDI

IPSC

Century Therapeutics and Fujifilm Cellular Dynamics have announced a new worldwide license deal and expansion of existing licenses for the development and commercialization of cell therapies for the treatment of autoimmune and inflammatory diseases.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:23 pm

LRHC

WHLR

La Rosa Holdings Corp. (LRHC) and Wheeler Real Estate Investment Trust, Inc. (WHLR) are identified as the most oversold stocks in the real estate sector, with RSI values of 20.61 and 29.59 respectively. LRHC has entered into a strategic referral partnership with Janover Inc., while WHLR has reported its financial and operating results for the three and nine months ended Sept. 30, 2023.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 12:15 pm